Natixis Advisors L.P. Raises Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Natixis Advisors L.P. boosted its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 16.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 24,792 shares of the biotechnology company’s stock after purchasing an additional 3,468 shares during the quarter. Natixis Advisors L.P.’s holdings in Axon Enterprise were worth $6,404,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Sands Capital Management LLC lifted its holdings in shares of Axon Enterprise by 31.1% during the 3rd quarter. Sands Capital Management LLC now owns 2,612,305 shares of the biotechnology company’s stock worth $519,823,000 after acquiring an additional 619,179 shares during the period. Westfield Capital Management Co. LP grew its stake in shares of Axon Enterprise by 184.3% during the 3rd quarter. Westfield Capital Management Co. LP now owns 696,193 shares of the biotechnology company’s stock valued at $138,535,000 after buying an additional 451,350 shares during the period. Polar Capital Holdings Plc increased its holdings in shares of Axon Enterprise by 292.0% during the 3rd quarter. Polar Capital Holdings Plc now owns 265,464 shares of the biotechnology company’s stock worth $52,825,000 after buying an additional 197,746 shares during the last quarter. International Assets Investment Management LLC acquired a new stake in shares of Axon Enterprise during the 4th quarter worth $39,907,000. Finally, Comerica Bank raised its position in shares of Axon Enterprise by 2,079.4% in the 3rd quarter. Comerica Bank now owns 141,750 shares of the biotechnology company’s stock worth $28,207,000 after buying an additional 135,246 shares during the period. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Trading Down 0.9 %

Shares of AXON opened at $309.09 on Friday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.66 and a current ratio of 3.00. Axon Enterprise, Inc. has a one year low of $175.37 and a one year high of $329.87. The stock has a 50-day moving average price of $310.86 and a 200 day moving average price of $267.73. The company has a market capitalization of $23.32 billion, a P/E ratio of 90.38 and a beta of 0.91.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Monday, May 6th. The biotechnology company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $0.95 by $0.20. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. The company had revenue of $460.74 million during the quarter, compared to analyst estimates of $441.57 million. During the same period last year, the business earned $0.51 EPS. The firm’s revenue for the quarter was up 34.3% compared to the same quarter last year. Sell-side analysts forecast that Axon Enterprise, Inc. will post 2.44 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the company. Robert W. Baird upped their price target on Axon Enterprise from $260.00 to $300.00 and gave the stock an “outperform” rating in a research note on Thursday, February 22nd. The Goldman Sachs Group raised their price target on shares of Axon Enterprise from $297.00 to $339.00 and gave the company a “buy” rating in a report on Wednesday, February 28th. StockNews.com downgraded shares of Axon Enterprise from a “buy” rating to a “hold” rating in a research note on Thursday, March 14th. JPMorgan Chase & Co. raised their target price on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “overweight” rating in a research note on Thursday, April 11th. Finally, Barclays upped their price target on shares of Axon Enterprise from $308.00 to $381.00 and gave the stock an “overweight” rating in a research report on Wednesday. Two investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $333.08.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.